Medical Lead Autoimmune Type 1 Diabetes Milano

Medical Lead Autoimmune Type 1 Diabetes
Milano
Lombardia, Milano

_Location: Milan_

- _ Job type: Permanent, Full-time_

- About the job

- At Sanofi, we are driven by one purpose - we chase the miracles of science to improve people's lives.

Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.

- We never settle and now we are creating a new paradigm with a first-in-class therapy in Autoimmune Diabetes (Type 1 Diabetes).

- Our newest core asset, resulting from the acquisition of Provention Bio in General Medicines Autoimmune Type 1 Diabetes space, aims at delaying the onset of stage 3 type 1 diabetes.

This means that for the first time, people at risk of developing this lifelong disease have fresh hope.

What delayed onset means is more time for children to be children with less healthcare and more care-free childhood.

The delay also gives families and healthcare professionals more time to prepare care plans for a later diagnosis.

- We now present an exciting opportunity for you to go further faster.

If you're excited by the prospect of bringing this innovative, first-in-class therapy to more people at risk then we want to hear from you as we build a great team who will work at the intersection of our growth in immune-mediated diseases and disease-modifying therapies in areas of high unmet need.

- This is a chance to bring your energy, expertise and experience to truly transformative and career-defining leadership roles where you can help change countless lives.

In return, you will have a rare opportunity in pharma - the chance to help disrupt and delay a debilitating and widespread disease.

- This really is a 'prime time' role offering you huge visibility and the chance to fast-track your career in healthcare.

- Innovation, patient focus and disruptive thinking are all key threads of our Play To Win culture.

- Our Autoimmune Type 1 Diabetes journey starts now and you can help us chart a new course - not only for Sanofi but for preventive healthcare.

Now is the time to add your strengths to ours!

- Our Team:

- We are seeking a highly motivated and visionary leader interested in shaping the management of people at risk of developing/or with T1 diabetes.

- As the Medical Autoimmune Diabetes (T1D) Lead, you will be primarily responsible to develop and implement the local medical strategy for a first-in-class therapy in Autoimmune Type 1 Diabetes.

- You will lead a best-in-class medical team that will establish credibility with T1D scientific community.

You will also shape the long-term strategy and medical team, considering post-launch period.

- You have a deep understanding of T1DM therapy area, the medical unmet needs, clinical practice guidelines, patient journey and competitive landscape.

You are recognized by key stakeholders as an expert in the field, with a significant network within the medical community.

You have extensive experience in medical affairs, including shaping therapy area strategies, medical insights gathering, building strategic partnerships, medical education, data dissemination, and omnichannel KOL engagement.

- Reporting to the country Medical Head, General Medicines this role is strategically positioned to realize the ambition for T1D by shaping the T1D disease strategy and building the launch strategy of this first-in-class therapy, contributing to the overall success of Sanofi and improving people's life.

Your core responsibilities will include:

- Building and leading the best-in-class T1D local medical team (including MSL's) with whom you will transform the paradigm of T1D management among the medical community

- Shaping with the Global Medical team (GMT) the Autoimmune Diabetes strategy that is translated in Integrated Growth Plan (IGP) including insights generation to feed the "Glocal" strategy

- Driving key pre-launch medical activities to ensure a successful local launch in collaboration with Commercial, Public Affairs and Market Access

- Identifying local evidence gaps (i. e. , required for regulatory submissions and reimbursement, LCM, product value proposition etc. )

for prioritization by GMT and, where applicable, driving the execution of local evidence generation plan

- Co-leading the development of patient pathway/journeys, patient support solutions and that improve patient experience and patient outcomes while meeting broader strategic objectives (i. e. , data generation)

- Co-design screening and monitoring strategy levering partnerships with the healthcare ecosystem players (e. g. , data registries to support stage 1/2 monitoring, diagnostic tests generalization and accessibility)

- Collaborating cross-functionally (e. g. , Commercial, Market Access, Public Affairs) to define a broad stakeholder engagement strategy by understanding how stakeholders impact each other in ecosystem (e. g. , KOLs, DOLs, scientific societies, PAGs, policy makers, payers, think-tanks, COEs, etc. )

and tailor engagement to their level of maturity to shape T1D parad